Munteanu, R., Moldovan, C., Tigu, A., Drula, R., Feder, R., Magdo, L., Jurj, A., Raduly, L., Budisan, L., Pirlog, R., Moldovan, A., Zimta, A., Braicu, C., Preda, A., Munteanu, V., Romitan, M., Gulei, D., & Ciuleanu, T. (2024). 5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Medicine and Pharmacy Reports, 97(4), 488-506. https://doi.org/10.15386/mpr-2777